-
Document de presse | 2022.01.11
Identification of a novel therapeutic target in Multiple Myeloma
Multiple myeloma is a cancer of the bone marrow, with a life expectancy of less than 5 years post-diagnosis. Proteasome inhibitors, the therapeutic backbone of current treatments, are very effective in treating newly diagnosed cancers but resistance or intolerance to these molecules inevitably develop, leading to relapses. While studying a neglected tropical disease[1], Buruli ulcer, researchers...
-
Page avancée | 2022.01.12
Institut Pasteur publications about SARS-CoV-2 / Covid-19
The Institut Pasteur’s list of scientific publications on SARS-CoV-2 coronavirus and Covid-19 disease.
-
News | 2022.01.12
French Prime Minister Jean Castex salutes the Institut Pasteur's expertise on emerging infectious diseases
French Prime Minister Jean Castex, accompanied by Frédérique Vidal, Minister of Higher Education, Research and Innovation, visited the Institut Pasteur on Monday January 10, 2022, to salute the efforts of scientists in the ongoing battle against COVID-19. The visit was an opportunity to highlight the need to strengthen preparedness for future emerging diseases. It was also an auspicious moment...
-
Document de presse | 2022.01.11
Anne-Lise Mamessier Giraud appointed Director of the Hearing Institute, an Institut Pasteur Center
Professor Anne-Lise Mamessier Giraud has been appointed as Director of the Hearing Institute, an Institut Pasteur center. She took up office on January 1, 2022 and succeeds Professor Christine Petit in the role.Anne-Lise Mamessier Giraud has been appointed as Director of the Hearing Institute, an Institut Pasteur center, for an initial five-year term, from January 1, 2022 to December 31, 2026....
-
News | 2022.01.18
Mapping antibiotic resistance of Escherichia coli
In a recently published study, scientists from the Institut Pasteur and its partners analyzed the genome of more than 700 strains of Escherichia coli bacteria to elucidate how antibiotic-resistant strains spread and evaluate the risk they represent.
-
Article | 2022.01.24
Education webinars
Since January 2012, with the support and collaboration of the Agence Universitaire de la Francophonie (AUF), the Association of Former Students of the Institut Pasteur (AAEIP) and the Education Department of the Institut Pasteur organize remote seminars by videoconference.
-
Document de presse | 2022.01.24
Pierre Buffet appointed as Medical Director of the Institut Pasteur
Professor Pierre Buffet has been appointed as Medical Director of the Institut Pasteur. Pierre Buffet took up his post on January 3, 2022 within the Institut Pasteur's Department of Scientific Affairs. Professor Pierre Buffet has been appointed as Medical Director within the Institut Pasteur's Department of Scientific Affairs, led by Senior Executive Scientific Vice-President Christophe d'...
-
Article | 2022.02.03
Gender Equality Plan
As part of its commitment to gender equality in the workplace, the Institut Pasteur has adopted a Gender Equality Plan (GEP). The GEP is a new step aimed at strengthening the Institut Pasteur's policy for equality, diversity and inclusion.
-
Document de presse | 2022.02.02
New anti-HIV antibody function discovered: tethering of viral particles at the surface of cells
Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1[1] antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures. The scientists found that certain antibodies already known for effectively targeting HIV-1 envelope (Env) protein can prevent infected cells from releasing viral particles...
-
Page avancée | 2022.02.07
2021 Theses and Ceremony
2021 Theses and Ceremony
